Combination therapy: the future of management for idiopathic pulmonary fibrosis?-Reference-Cited by-同舟云学术

Combination therapy: the future of management for idiopathic pulmonary fibrosis?

Published:2014-11 Issue:11 Volume:2 Page:933-942
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Wuyts Wim A,Antoniou Katerina M,Borensztajn Keren,Costabel Ulrich,Cottin Vincent,Crestani Bruno,Grutters Jan C,Maher Toby M,Poletti Venerino,Richeldi Luca,Vancheri Carlo,Wells Athol U

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference63 articles.

1. Prognostic significance of histopathological subsets in idiopathic pulmonary fibrosis;Bjoraker;Am J Respir Crit Care Med,1998

2. Idiopathic pulmonary fibrosis;King;Lancet,2011

3. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials;Noble;Lancet,2011

4. Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis;Richeldi;N Engl J Med,2011

5. High-dose acetylcysteine in idiopathic pulmonary fibrosis;Demedts;N Engl J Med,2005

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical characteristics of high-altitude interstitial lung disease: a two-center, retrospective, observational study;2024-09-08

2. Emerging pharmacological options in the treatment of idiopathic pulmonary fibrosis (IPF);Expert Review of Clinical Pharmacology;2024-08-27

3. Pirfenidone and nintedanib exert additive antifibrotic effects by the SPP1-AKT pathway in macrophages and fibroblasts;Biochemical and Biophysical Research Communications;2024-07

4. Chitosan/bovine serum albumin layer-by-layer assembled particles for non-invasive inhaled drug delivery to the lungs;International Journal of Biological Macromolecules;2024-06

5. Combination of losartan with pirfenidone: a protective anti-fibrotic against pulmonary fibrosis induced by bleomycin in rats;Scientific Reports;2024-04-16